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Background: Dendritic cells are potent and specialized antigen presenting cells,
which play a crucial role in initiating and amplifying both the innate and adaptive
immune responses. The dendritic cell-based vaccination against cancer has been
clinically achieved promising successes. But there are still many challenges in its
clinical application, especially for how to identify the functional states.
Methods: The CD14+ monocytes were isolated from human peripheral blood after
plastic adherence and purified to approximately 98% with cocktail immunomagnetic
beads. The immature dendritic cells and mature dendritic cells were induced by
traditional protocols. The resulting dendritic cells were cocultured with normal cells
and cancer cells. The functional state of dendritic cells including immature dendritic
cells (imDCs) and mature dendritic cells (mDCs) under different conditioned
microenvironments were investigated by Fourier transformed infrared spectroscopy
(FTIR) and molecular biological methods.
Results: The results of Fourier transformed infrared spectroscopy showed that the
gene transcription activity and energy states of dendritic cells were specifically
suppressed by tumor cells (P < 0.05 or 0.01). The expression levels of NF-kappa B
(NF-κB) in dendritic cells were also specifically inhibited by tumor-derived factors
(P < 0.05 or 0.01). Moreover, the ratios of absorption intensities of Fourier transformed
infrared spectroscopy at given wave numbers were closely correlated with the
expression levels of NF-κB (R2:0.69 and R2:0.81, respectively).
Conclusion: Our results confirmed that the ratios of absorption intensities of Fourier
transformed infrared spectroscopy at given wave numbers were positively correlated
with the expression levels of NF-κB, suggesting that Fourier transformed infrared
spectroscopy technology could be clinically applied to identify the functional states
of dendritic cell when performing dendritic cell-based vaccination. It’s significant for
the simplification and standardization of dendritic cell-based vaccination clinical
preparation protocols.
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of cells, NF-κB© 2014 Dong et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Dendritic cells (DCs) are potent and specialized antigen-presenting cells with the
capabilities of capturing, processing antigens and presenting tumor associated antigens
to naive-T cells, therefore inducing tumor-specific immune response [1,2]. DCBV is a
promising immunotherapy against cancer, which has been shown to effectively work in
mice and human. However, there are still many challenges in clinical application of
DCBV, such as antigen selection, ways of antigen loading, pathways and intervals of
injection, and identification of the functional state of DCs [3-6]. Many strategies have
been focused on the improvement of the efficiency of DCBV [1,5,7], nevertheless, little
about identification of functional state of cells. Especially, it was clinically cumbersome
for the preparation of DCBV and difficult to determine the functional state of DCs.
Therefore, how to measure the functional state of DCs with a convenient, reliable and
non-invasive method is practically for DCBV preparation protocols.
FTIR is a spectroscopic technique which is used to obtain an infrared spectrum of
absorption, emission, photoconductivity or Raman scattering of solid, liquid or gas [8].
With its simple, rapid, and reliable analysis, it has been widely used in the studies of
medicine, e.g. cancer identification [9]. Presently, it is well confirmed that DCs are
dysfunctional in cancer-bearing hosts [10-13]. NF-κB is a major transcription factor
that regulates genes responsible for both the innate and adaptive immune response.
Karin and colleagues found that NF-κB is associated with the immunological functions
of mast cells and DCs in the liver, which is shared by many signal pathways. Moreover,
the activation of NF-κB in these cells can lead to the expression of cytokines and
chemokines [14,15]. RelB is a subunit of NF-κB transcription factor which played a key
role in the maturity of DCs [16]. Recent evidences demonstrated that the generation
of tolerogenic DCs and immune tolerance were induced by RelB-silence in organ
transplantation [17-20]. Several groups suggested that the immunological functions of
DCs are deteriorated by tumor through the inhibition of NF-κB function [14,21,22].
Therefore, NF-κB was selected as the indicator of gene transcription of DCs in the present
study. In this study, the functional states of DCs at different differentiation stages (imDCs
and mDCs) under various conditioned microenvironment were measured by FTIR and
molecular biological technologies. The results showed that the gene transcription
activity and energy states of DCs were suppressed by tumor cells, moreover, the
absorption intensities of FTIR at given wave number were closely correlated with
the expression levels of RelB. It laid the foundation for the application of FTIR to
the identification of functional states in the DCBV preparation protocol.Materials and methods
Isolation of monocytes and generation of DCs
The DCs were generated from fresh peripheral blood mononuclear cells (PBMCs) of
healthy human subject as described by Steinman [23] with minor modification. Details
as follows: CD14+ monocytes were obtained from peripheral blood after plastic adherence
and purified to approximately 98% by elimination of un-mononuclear cells (T-cells, NK
cells, B cells, neutrophile cells and dendritic cells) with cocktail immunomagnetic beads
(anti-CD3, anti-CD7, anti-CD19, anti-CD56, anti-CD45RA and anti-IgE antibody). The
monocytes were cultured in RPMI 1640 medium supplemented with 20% fetal bovine
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granulocyte-macrophage colony stimulating factor (rhGM-CSF) and 100 ng/ml recombinant
human interleukin-4 (rhIL-4). After 7 days, collected suspension of cells was imDCs,
and 10 ng/ml recombinant human tumor necrosis factor (rhTNF-α) was added and
the imDCs were further cultured for another 3 days to obtain mDCs. The phenotypes
of DCs were analyzed by staining the cell surface with FITC or PE-conjugated
mouse antibodies to human CD11c, CD40, CCR7, CD80, CD83, CD86 and HLA-DR. The
viabilities of cells were detected by trypan blue staining.Isolation and culture of human umbilical vein endothelial cells (HUVECs)
As one of the normal controls, HUVECs were separated from umbilical cords (provided
by the Third Hospital of Peking University) and maintained in M199 medium/20% FBS.
The experiments were conducted with strict observance of the moral principles and
guidelines for human investigation in China, where the experiments were performed. The
cells were identified by their polyangular shape and the presence of factor VIII-related
antigen (Santa Cruz Biotechnology Inc., Santa Cruz, USA) in their cytoplasm.Cultures of cell lines
Hepatocellular carcinoma cell line Bel7402 (HCC) and normal hepatocyte cell line
QSG-7701 (HC) were gifted by Dr. Ye Zhang (Peking University). Cells (2 × 106) were
rinsed with phosphate-buffered saline (PBS) and cultivated in RPMI-1640 with 10%
fetal bovine serum (FBS) at 37°C, 5% CO2 and 95% humidity. Cells were digested every
3 days by trypsinization with 10% trypsin/EDTA. The cells in logarithmic phase were
collected to co-cultured with DCs.Co-culture of DCs with different cells
The co-culture of imDCs or mDCs (2 × 107) with HUVEC, HCC and HC (2 × 106) were
performed in the Transwell system (0.6 μm pores, Corning corporation) for 24 hours,
respectively. The HUVEC and HC were as negative control. DCs were seeded on the upper
compartment of Transwell chambers, HUVEC, HCC and HC were placed in the lower
compartment respectively. These DCs were labeled as imDCs +HUVEC, mDCs +HUVEC,
imDCs +HC, mDCs +HC, imDCs +HCC, mDCs +HCC. For blank controls, DCs were
cultured in complete medium supplemented with 150 ng/ml rhGM-CSF and 100 ng/ml
rhIL-4 and DCs were cultured in RPMI-1640 plus 20% FBS without rhGM-CSF and rhIL-4
were labeled as DCs + nonGF (including imDCs + nonGF and nonGF).Treatments of DCs
In order to determine susceptibility of FTIR used in the measurement of cell gene
transcription activity, imDCs and mDCs were processed by 5 nM ASA (Santa Cruz
Biotechnology Inc., Santa Cruz, USA), a specific inhibitor of NF-κB, for 24 hours
and named as imDCs + ASA and mDCs + ASA.FTIR measurements
Cells were adjusted to 2 × 106/ml and washed twice with 0.9% NaCl in 1000 RMP
centrifugation for 6 min. The supernatant was removed by centrifugation. The cells were
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the cell suspension was evaporated, until the formation of 2 ~ 3 mm film in the window.
The crystals were fixed in the sample holder and covered with another CaF2 crystal. To
measure the background spectrum of a blank group, before each sample measurement by
Infrared Spectrometer (ENXUS-470 FT-IR), blank control with 0.9% NaCl was used in
the detection of infrared absorption spectra. The parameters of measurement were the
scanning range of 400 ~ 4000 cm-1, the resolution of 8 cm-1, scanning the stack up to 256
times. The data analyses were performed using OMNIC6.0 software. All the spectra were
subtracted blank control, and Fourier self-deconvolution, broadband = 56.4, sensitivity
enhancement factor = 2.6, in deconvolution spectrum.Western blots
Cells were lysed with RIPA buffer (20 mM sodium phosphate, pH 7.4, 150 mM sodium
chloride, 1% Triton X-100, 5 mM EDTA, 200 μM phenymethylsulfonyl fluoride, 1 μg/ml
aprotinin, 5 μg/ml leupeptin, 1 μg/ml pepstatin and 500 μM Na3VO4). The protein
extracts were electrophoresed on 12% ~ 14% SDS-polyacrylamide gel and transferred onto
a nitrocellulose membrane (Invitrogen, USA). After blocking with 5% BSA in 0.1% Tween
20 in PBS, membranes were probed with primary antibodies. Anti-RelB and anti-β-actin
antibodies (Sigma) were diluted in blocking buffer and incubated with the blots overnight at
4°C. The bound primary antibodies were probed with a 1:2000 diluted secondary antibody
(goat anti-human IgG-HRP antibody) and visualized by the ECL chemiluminescence system
(Amersham, USA). The gray values of proteins were measured by Image J (1.45). The
expression levels of proteins were normalized to those of corresponding β-actin.Statistical analyses
All experiments were performed at least three times. The results were presented as
means ± standard deviations (SD). Analysis of variance (ANOVA two-way) of SPSS
(11.5) was used for statistical data analyses. Correlation analyses were performed by
Excel (2007).Results
Characterizations of imDCs and mDCs
The expression profiles of co-stimulatory molecules, including CD11c, CD40, HLA-DR,
CCR7, CD80, CD83 and CD86, were analyzed for both imDCs and mDCs with flow
cytometry. The expression levels of these co-stimulatory molecules in mDCs were
up-regulated by IL-10, suggesting that imDCs and mDCs were successfully induced [24,25].The energy states and gene transcription activity in DCs co-cultured with different cells
According to the results of the Ramesh group [26,27], the absorption intensity
ratios of A1020/A1545, A1121/A1545, A1030/A1080 and A1030/A2924 respectively correspond to
DNA/amide II (relative content of DNA and proteins), RNA/amide II (transcriptional
states), glucose/phosphate (metabolic turnover) and glucose/phospholipid (de onvo
synthesis of phospholipids at the expense of free glucose). All spectra were subjected to
Fourier self-deconvolution, and there was no wave number shift in the spectra
(Figure 1). The ratios of absorption intensities of A1020/A1545, A1121/A1545, A1030/A1080 and
Figure 1 The schematic diagram of infrared spectrum of the contents of lipids and proteins in cells.
Cells were adjusted to 2 × 106/ml and washed twice with 0.9% NaCl in 1000 RPM centrifugation for 6 min.
The supernatant was removed by centrifugation. The cells were transferred to the CaF2 crystals at 37°C and
left to stand for about 10 min. The water in the cell suspension was evaporated, until the formation of
2 ~ 3 mm film in the window. The crystals were fixed in the sample holder and covered with another CaF2
crystal. To measure the background spectrum of a blank group, before each sample measurement by
Infrared Spectrometer (ENXUS-470 FT-IR), blank control with 0.9% NaCl was used in the detection of infrared
absorption spectra. The parameters of measurement were the scanning range of 400 ~ 4000 cm-1, the
resolution of 8 cm-1, scanning the stack up to 256 times. The data analyses were performed using OMNIC6.0
software. All the spectra were subtracted blank control, and Fourier self-deconvolution, broadband = 56.4,
sensitivity enhancement factor = 2.6, in deconvolution spectrum.
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Table 1, the A1121/A1545, A1030/A1080 and A1030/A2924 of DCs +HCC and DCs + ASA were
significantly lower than those of controls (*P < 0.05 or **P < 0.01), moreover, there was no
difference among DCs +HUVEC, DCs +HC and DCs (P > 0.05).The expression levels of RelB were down-regulated in DCs co-cultured with HCCs
RelB is a subunit of NF-κB, whose expression levels are closely associated with the mature
state of DCs [28]. As shown in Figure 2, the expression levels of RelB in DCs +HCC
(imDCs and mDCs) were markedly inhibited by tumor cells (*P < 0.05 or **P < 0.01).Table 1 The ratios of absorption intensity at given wave number in DCs under different
conditioned microenvironments (X ± SD)
Types of DCs A1020/A1545 A1121/A1545 A1030/A1080 A1030/A2924
DNA/amide II RNA/amide II Glucose/phospholipid Glucose/phosphate
DCs imDCs 3.782 ± 0.016 2.953 ± 0.060 1.274 ± 0.046 0.753 ± 0.033
mDCs 0.531 ± 0.032 1.219 ± 0.039 0.169 ± 0.022 0.957 ± 0.058
DCs + nonGF imDCs + nonGF 3.655 ± 0.027 1.822 ± 0.086 1.383 ± 0.031 0.764 ± 0.028
mDCs + nonGF 0.583 ± 0.026 0.877 ± 0.051 0.423 ± 0.015 0.604 ± 0.022
DCs + HUVEC imDCs + HUVEC 3.452 ± 0.187 2.769 ± 0.171 1.302 ± 0.054 0.748 ± 0.048
mDCs + HUVEC 0.549 ± 0.079 1.233 ± 0.089 0.152 ± 0.103 0.933 ± 0.021
DCs + HC imDCs + HC 3.556 ± 0.045 2.843 ± 0.062 1.266 ± 0.082 0.712 ± 0.067
mDCs + HC 0.586 ± 0.034 1.176 ± 0.095 0.149 ± 0.061 0.926 ± 0.043
DCs + HCC imDCs + HCC 3.721 ± 0.027 0.603 ± 0.004* 0.382 ± 0.010* 0.302 ± 0.017*
mDCs + HCC 0.577 ± 0.027 0.361 ± 0.021* 0.423 ± 0.007* 0.408 ± 0.023*
DCs + ASA imDCs + ASA 3.718 ± 0.018 0.296 ± 0.021** 0.351 ± 0.012** 0.281 ± 0.024**
mDCs + ASA 0.488 ± 0.024 0.125 ± 0.009** 0.107 ± 0.009** 0.386 ± 0.031**
imDCs + HCC and mDCs + HCC respectively compared with imDCs and mDCs: *p < 0.05; imDCs + ASA and mDCs + ASA






















Figure 2 The expression levels of RelB in DCs under different conditioned microenvironments. Cells
were lysed with RIPA buffer (20 mM sodium phosphate, pH 7.4, 150 mM sodium chloride, 1% Triton X-100,
5 mM EDTA, 200 μM phenymethylsulfonyl fluoride, 1 μg/ml aprotinin, 5 μg/ml leupeptin, 1 μg/ml pepstatin
and 500 μM Na3VO4). The protein extracts were electrophoresed on 12% ~ 14% SDS-polyacrylamide gel and
transferred onto a nitrocellulose membrane (Invitrogen, USA). After blocking with 5% BSA in 0.1% Tween 20
in PBS, membranes were probed with primary antibodies. Anti-RelB and anti-β-actin antibodies (Sigma) were
diluted in blocking buffer and incubated with the blots overnight at 4°C. The bound primary antibodies were
probed with a 1:2000 diluted secondary antibody (goat anti-human IgG-HRP antibody) and visualized by the
ECL chemiluminescence system (Amersham, USA). The gray values of proteins were measured by Image J
(1.45). The expression levels of proteins were normalized to those of corresponding β-actin. Compared with
DCs: *P < 0.05 or **P < 0.01.
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NF-κB inhibitor ASA, which were not affected by HUVEC and HC (P > 0.05).Analyses of linear regression
To investigate the correlations between the expression levels of NF-κB in DCs and the
ratios of absorption intensities at given wave numbers, the analyses of linear regression
were performed. The results (Figure 3) showed that the values of A1121/A1545 of DCs +HCC
(imDCs +HCC and mDCs +HCC) were closely correlated with the expression levels of
NF-κB (R2:0.69 and R2:0.81, respectively).Discussion
Along with the first DCs-based therapeutic cancer vaccine was approved by the Food
and Drug Administration of USA, DCBV have been having a promising future because
it was demonstrated feasibilities and safeties [5,29]. Clinically, DCBV has been achieved
some successes, despite their induction of tumor-specific T cell responses in many
patients and occasional complete tumor regressions, there are still many conundrums,
including antigen selection, injection of pathways and intervals, immune escape of
cancer, identifications of DCs functional state and so on, need to be overcome
[1,5,7,30]. Moreover, the preparation protocols of DCBV also should be simplified and
standardized for their better clinical applications. The present study was focused on the
measurement of functional states of DCs with FTIR in order to find a convenient,
reliable and non-invasive method for DCBV preparation protocol.
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Figure 3 Analyses of linear regression of the activities gene transcription and the expression levels
of NF-κB. A. imDCs (R2: 0.69), B. mDCs (R2: 0.81).
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radicals in molecules in response to changes in cell structure, conformation and micro-
environment. It has become a useful tool for measuring the macromolecular characteristics
and biochemical event. Here, the functional states of imDCs and mDCs under different
conditioned microenvironments by FTIR spectroscopy and molecular biological methods.
The ratio of A1121/A1545 corresponds to an RNA/amide, which reflects the gene
transcription states of cells. As shown in Table 1, the ratios of A1121/A1545 of DCs +HCC
were significantly lower than those of DCs (*P < 0.05) and there were no difference among
DCs +HUVEC, DCs +HC and DCs (P > 0.05), suggesting that the gene transcription
states of DCs were specifically suppressed by HCC, this is consistent with others
[14,15,31]. The inhibition of gene transcription state might be associated with the
abnormal expressions of some important proteins in DCs leading to the dysfunctional
immune responses of the host. Under the tumor microenvironment, NF-κB plays an
important role in cancer development and progression because it’s a crucial transcription
factor which regulates immune functions [32]. Kuwabara and colleagues found that the
NF-κB signaling pathways perform a critical role in CCR7-mediated IL-23 production
[33]. The RelB subunit of NF-κB controls DCs maturation and may be therapeutically
targeted to manipulate the T cell response in disease. Several groups have reported
that RelB promoted DC activation, and RelB-silenced DCs could induce donor-specific
hypo-responsiveness and impair immune functions of T cells [28,34]. The tumor
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down-regulate the expression levels of chemokines, adhesion molecule and costimulatory
molecules by suppressing expression of NF-κB [35,36]. Therefore, the expression levels of
NF-κB in cells were selected as one of the indicators of DCs functional states. To confirm
the results of FTIR, DCs were treated with NF-κB inhibitor ASA, the data (Table 1)
showed that the ratio of A1121/A1545 of DCs was indeed markedly decreased by
ASA, this was consistent with the data of western blotting (Figure 2). Moreover,
the ratios of A1121/A1545 (Figure 3) were closely correlated with the expression
levels of NF-κB (R2: 0.69 and 0.81). Thus, these results have supported the idea
that FTIR could be clinically applied to estimate the functional states of DCs.
The ratios of A1030/A1080 and A1030/A2924 respectively respond to glucose/phospholipids
and glucose/phosphate, which reflect the energy states of cells. As shown in Table 1, the
ratios of A1030/A1080 and A1030/A2924 of DCs + HCC were lower than those of DCs
(P < 0.05) and there were no difference among DCs + HUVEC, DCs + HC and DCs
(P > 0.05), indicating that the energy states of DCs were also significantly and specifically
impaired by HCC. It could be inferred the insufficient glucose content of DCs could not
be able to afford enough energy to perform their physiological functions, such as
migration in peripheral tissue and interaction with naive T cells in lymph node.
This could explain why the overall number of DCs reaching a lymph node is very
small (probably less than 1%) after their intracutaneous injection into a host loading
tumor [6,7]. In addition, the insufficient energy supplies caused by tumor cells -derived
factors might affect the other functions of DCs, such as the metabolisms of protein and
lipid, this inevitably might be associated with the uptake, processing and presenting of
antigen of DCs. It was one of the possible reasons of the deteriorated motilities and
immune regulatory functions of DCs under tumor microenvironment.
Taken together, the present study suggested that gene transcriptional activity and energy
states of DCs were inhibited by HCCs, this might be one of aspects of tumor immune
escape. The ratios of absorption intensity of FT-IR at given wave number were closely
correlated with the expression levels of NF-κB. It laid the foundation for the application of
FT-IR to the identification of functional states in the DCBV preparation protocol.
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